Par Health USA

1 recall on record · Last recall: Jun 12, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious

Class II — Moderate

Class III — Low Risk

Recall Timeline

Class IIFDAJun 12, 2026

Par Health USA — Crystallization; identified as Buprenorphine free base

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05 Crystallization; identified as Buprenorphine free base

Track Par Health USA recalls automatically

Get an alert when a matching Par Health USA recall turns up.

Start Free Trial